These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prediction of lymph node status in superficial esophageal carcinoma. Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651 [TBL] [Abstract][Full Text] [Related]
5. The use of neural networks in identifying risk factors for lymph node metastasis and recommending management of t1b esophageal cancer. Sgourakis G; Gockel I; Lyros O; Lanitis S; Dedemadi G; Polotzek U; Karaliotas C; Lang H Am Surg; 2012 Feb; 78(2):195-206. PubMed ID: 22369829 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer. Yoshii T; Ohkawa S; Tamai S; Kameda Y Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622 [TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070 [TBL] [Abstract][Full Text] [Related]
9. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733 [TBL] [Abstract][Full Text] [Related]
10. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. Boys JA; Worrell SG; Chandrasoma P; Vallone JG; Maru DM; Zhang L; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Molena D; Watson TJ; DeMeester SR J Gastrointest Surg; 2016 Jan; 20(1):6-12; discussion 12. PubMed ID: 26408330 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma. Li B; Chen H; Xiang J; Zhang Y; Kong Y; Garfield DH; Li H J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1198-203. PubMed ID: 23988285 [TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk. Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604 [TBL] [Abstract][Full Text] [Related]
14. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. Merkow RP; Bilimoria KY; Keswani RN; Chung J; Sherman KL; Knab LM; Posner MC; Bentrem DJ J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25031273 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Choi JY; Park YS; Jung HY; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Lee GH; Cho KJ; Kim JH Gastrointest Endosc; 2011 May; 73(5):881-9, 889.e1-2. PubMed ID: 21392755 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic submucosal dissection vs endoscopic mucosal resection for superficial esophageal cancer. Guo HM; Zhang XQ; Chen M; Huang SL; Zou XP World J Gastroenterol; 2014 May; 20(18):5540-7. PubMed ID: 24833885 [TBL] [Abstract][Full Text] [Related]
17. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Bollschweiler E; Baldus SE; Schröder W; Prenzel K; Gutschow C; Schneider PM; Hölscher AH Endoscopy; 2006 Feb; 38(2):149-56. PubMed ID: 16479422 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the therapeutic effects of endoscopic submucosal dissection and minimally invasive esophagectomy for T1 stage esophageal carcinoma. Gong L; Yue J; Duan X; Jiang H; Zhang H; Zhang X; Yu Z Thorac Cancer; 2019 Nov; 10(11):2161-2167. PubMed ID: 31556243 [TBL] [Abstract][Full Text] [Related]
19. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Akutsu Y; Uesato M; Shuto K; Kono T; Hoshino I; Horibe D; Sazuka T; Takeshita N; Maruyama T; Isozaki Y; Akanuma N; Matsubara H Ann Surg; 2013 Jun; 257(6):1032-8. PubMed ID: 23108117 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer. Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J Digestion; 2019; 99(4):293-300. PubMed ID: 30176662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]